Published in BMC Med Genet on February 22, 2010
The BDNF Val(66)Met polymorphism is associated with escitalopram response in depressed patients. Psychopharmacology (Berl) (2014) 0.79
Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science (1996) 16.04
The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell (2003) 12.50
5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci (2005) 10.13
Allelic variation of human serotonin transporter gene expression. J Neurochem (1996) 7.08
Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet (2006) 6.27
Statistics notes. The odds ratio. BMJ (2000) 5.61
Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children. Biol Psychiatry (2006) 3.97
An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk. Alcohol Clin Exp Res (2005) 3.94
The developmental role of serotonin: news from mouse molecular genetics. Nat Rev Neurosci (2003) 3.79
Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531. Mol Psychiatry (2006) 3.73
Long story short: the serotonin transporter in emotion regulation and social cognition. Nat Neurosci (2007) 3.66
Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter. Nat Neurosci (2004) 3.56
The epidemiology of mental retardation: challenges and opportunities in the new millennium. Ment Retard Dev Disabil Res Rev (2002) 3.26
Histone modifications around individual BDNF gene promoters in prefrontal cortex are associated with extinction of conditioned fear. Learn Mem (2007) 2.99
Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters. Genomics (2007) 2.89
A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry (1996) 2.60
The prevalence of mental retardation: a critical review of recent literature. Dev Med Child Neurol (1997) 2.54
Neural correlates of genetically abnormal social cognition in Williams syndrome. Nat Neurosci (2005) 2.50
The AP-2 family of transcription factors. Genome Biol (2005) 2.46
Impaired stress-coping and fear extinction and abnormal corticolimbic morphology in serotonin transporter knock-out mice. J Neurosci (2007) 2.33
Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression. Arch Gen Psychiatry (2007) 2.05
Serotonin transporter mRNA levels are associated with the methylation of an upstream CpG island. Am J Med Genet B Neuropsychiatr Genet (2007) 1.97
Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology (2007) 1.91
Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann Neurol (2001) 1.87
A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo. Proc Natl Acad Sci U S A (1999) 1.86
Evidence of linkage between the serotonin transporter and autistic disorder. Mol Psychiatry (1997) 1.71
Human brain derived neurotrophic factor (BDNF) genes, splicing patterns, and assessments of associations with substance abuse and Parkinson's Disease. Am J Med Genet B Neuropsychiatr Genet (2005) 1.60
Dendritic pathology in mental retardation: from molecular genetics to neurobiology. Genes Brain Behav (2006) 1.57
Brain-derived neurotrophic factor polymorphism Val66Met influences cognitive abilities in the elderly. Genes Brain Behav (2007) 1.47
The brain-derived neurotrophic factor Val66Met polymorphism is associated with age-related change in reasoning skills. Mol Psychiatry (2006) 1.46
Serotonin and brain development: role in human developmental diseases. Brain Res Bull (2001) 1.39
Brain-derived neurotrophic factor promotes the maturation of GABAergic mechanisms in cultured hippocampal neurons. J Neurosci (2002) 1.35
Barrel pattern formation requires serotonin uptake by thalamocortical afferents, and not vesicular monoamine release. J Neurosci (2001) 1.34
Excessive activation of serotonin (5-HT) 1B receptors disrupts the formation of sensory maps in monoamine oxidase a and 5-ht transporter knock-out mice. J Neurosci (2001) 1.33
BDNF promotes the regenerative sprouting, but not survival, of injured serotonergic axons in the adult rat brain. J Neurosci (2000) 1.32
Serum neurotrophin concentrations in autism and mental retardation: a pilot study. Brain Dev (2004) 1.26
Interaction between BDNF Val66Met and dopamine transporter gene variation influences anxiety-related traits. Neuropsychopharmacology (2007) 1.21
Presence of multiple functional polyadenylation signals and a single nucleotide polymorphism in the 3' untranslated region of the human serotonin transporter gene. J Neurochem (1999) 1.18
BDNF increases monoaminergic activity in rat brain following intracerebroventricular or intraparenchymal administration. Brain Res (1996) 1.12
Aberrant brain activation during gaze processing in boys with fragile X syndrome. Arch Gen Psychiatry (2008) 1.02
Hyperserotoninemia and serotonin receptor antibodies in children with autism but not mental retardation. Biol Psychiatry (1997) 0.99
Loss of brain-derived neurotrophic factor gene allele exacerbates brain monoamine deficiencies and increases stress abnormalities of serotonin transporter knockout mice. J Neurosci Res (2005) 0.97
Serotonin transporter function, but not expression, is dependent on brain-derived neurotrophic factor (BDNF): in vivo studies in BDNF-deficient mice. J Neurochem (2007) 0.95
Genetic variation of serotonin function and cognitive control. J Cogn Neurosci (2007) 0.94
Alternative splicing of the human serotonin transporter gene. J Neurochem (1997) 0.91
Electrophysiological measurements of anterior cingulate function. J Neural Transm (Vienna) (2002) 0.90
X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am J Hum Genet (2004) 5.15
Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. Am J Hum Genet (2005) 3.87
Pleiotropic effects of CEP290 (NPHP6) mutations extend to Meckel syndrome. Am J Hum Genet (2007) 3.42
Mutations in the JARID1C gene, which is involved in transcriptional regulation and chromatin remodeling, cause X-linked mental retardation. Am J Hum Genet (2004) 2.99
ARX, a novel Prd-class-homeobox gene highly expressed in the telencephalon, is mutated in X-linked mental retardation. Hum Mol Genet (2002) 2.30
CSF biomarker variability in the Alzheimer's Association quality control program. Alzheimers Dement (2013) 1.90
Mutation frequencies of X-linked mental retardation genes in families from the EuroMRX consortium. Hum Mutat (2007) 1.68
Mutations in the polyglutamine binding protein 1 gene cause X-linked mental retardation. Nat Genet (2003) 1.61
High prevalence of SLC6A8 deficiency in X-linked mental retardation. Am J Hum Genet (2004) 1.55
Mutations in the ZNF41 gene are associated with cognitive deficits: identification of a new candidate for X-linked mental retardation. Am J Hum Genet (2003) 1.52
Transcription factor SOX3 is involved in X-linked mental retardation with growth hormone deficiency. Am J Hum Genet (2002) 1.45
Mutations of the ANG gene in French patients with sporadic amyotrophic lateral sclerosis. Arch Neurol (2008) 1.39
ZNF674: a new kruppel-associated box-containing zinc-finger gene involved in nonsyndromic X-linked mental retardation. Am J Hum Genet (2005) 1.38
Nonsyndromic X-linked mental retardation: where are the missing mutations? Trends Genet (2003) 1.30
What was the set of ubiquitin and ubiquitin-like conjugating enzymes in the eukaryote common ancestor? J Mol Evol (2009) 1.30
Mutations in the FTSJ1 gene coding for a novel S-adenosylmethionine-binding protein cause nonsyndromic X-linked mental retardation. Am J Hum Genet (2004) 1.29
Fetal fibrochondrogenesis at 26 weeks' gestation. Prenat Diagn (2002) 1.12
1H-NMR-based metabolomic profiling of CSF in early amyotrophic lateral sclerosis. PLoS One (2010) 1.12
Autism and nonsyndromic mental retardation associated with a de novo mutation in the NLGN4X gene promoter causing an increased expression level. Biol Psychiatry (2009) 1.11
Disruptions of the novel KIAA1202 gene are associated with X-linked mental retardation. Hum Genet (2005) 1.10
Deficit in BDNF does not increase vulnerability to stress but dampens antidepressant-like effects in the unpredictable chronic mild stress. Behav Brain Res (2009) 1.08
Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease. Neurochem Int (2008) 1.05
Mild phenotypes in a series of patients with Opitz GBBB syndrome with MID1 mutations. Am J Med Genet A (2005) 1.04
Variable effects of chronic subcutaneous administration of rotenone on striatal histology. J Comp Neurol (2004) 1.04
Neuronal differentiation of stem cells isolated from adult muscle. J Neurosci Res (2002) 1.03
Möbius sequence, Robin complex, and hypotonia: severe expression of brainstem disruption spectrum versus Carey-Fineman-Ziter syndrome. Am J Med Genet A (2004) 1.02
Fetal exposure to teratogens: evidence of genes involved in autism. Neurosci Biobehav Rev (2010) 1.02
In-frame deletion in MECP2 causes mild nonspecific mental retardation. Am J Med Genet (2002) 1.00
MCT8 mutation analysis and identification of the first female with Allan-Herndon-Dudley syndrome due to loss of MCT8 expression. Eur J Hum Genet (2008) 1.00
Behavior and serotonergic disorders in rats exposed prenatally to valproate: a model for autism. Neurosci Lett (2009) 0.96
Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer. Lung Cancer (2007) 0.95
Metabolomics in cerebrospinal fluid of patients with amyotrophic lateral sclerosis: an untargeted approach via high-resolution mass spectrometry. J Proteome Res (2013) 0.94
Transcriptional silencing of the TFPI-2 gene by promoter hypermethylation in choriocarcinoma cells. Biol Chem (2003) 0.94
Loss of SLC38A5 and FTSJ1 at Xp11.23 in three brothers with non-syndromic mental retardation due to a microdeletion in an unstable genomic region. Hum Genet (2007) 0.93
Renal impairment and ischemic stroke risk assessment in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project. J Am Coll Cardiol (2013) 0.92
Refinement of the NHS locus on chromosome Xp22.13 and analysis of five candidate genes. Eur J Hum Genet (2002) 0.92
Amyotrophic lateral sclerosis: a hormonal condition? Amyotroph Lateral Scler (2012) 0.91
Specific clinical and brain MRI features in mentally retarded patients with mutations in the Oligophrenin-1 gene. Am J Med Genet A (2004) 0.89
Inv(X)(p21.1;q22.1) in a man with mental retardation, short stature, general muscle wasting, and facial dysmorphism: clinical study and mutation analysis of the NXF5 gene. Am J Med Genet A (2003) 0.89
Adult reserve stem cells and their potential for tissue engineering. Cell Biochem Biophys (2004) 0.88
Co-occurrence of progressive anarthria with an S393L TARDBP mutation and ALS within a family. Amyotroph Lateral Scler (2011) 0.88
Hemin decreases cardiac oxidative stress and fibrosis in a rat model of systemic hypertension via PI3K/Akt signalling. Cardiovasc Res (2011) 0.87
Confirmation of the amyloidogenic process in posterior cortical atrophy: value of the Aβ42/Aβ40 ratio. J Alzheimers Dis (2013) 0.85
Apical left ventricular aneurysm without atrio-ventricular block due to a lamin A/C gene mutation. Eur J Heart Fail (2003) 0.85
A deletion causing NF2 exon 9 skipping is associated with familial autosomal dominant intramedullary ependymoma. Neuro Oncol (2013) 0.84
Study of the HFE gene common polymorphisms in French patients with sporadic amyotrophic lateral sclerosis. J Neurol Sci (2012) 0.84
1H-13C NMR-based urine metabolic profiling in autism spectrum disorders. Talanta (2013) 0.83
Mutation screening of brain-expressed X-chromosomal miRNA genes in 464 patients with nonsyndromic X-linked mental retardation. Eur J Hum Genet (2006) 0.83
Association between divalent metal transport 1 encoding gene (SLC11A2) and disease duration in amyotrophic lateral sclerosis. J Neurol Sci (2011) 0.83
Homozygous SMN2 deletion is a protective factor in the Swedish ALS population. Eur J Hum Genet (2012) 0.83
Gastrointestinal symptoms resembling ulcerative proctitis caused by larvae of the drone fly Eristalis tenax. Pathog Glob Health (2014) 0.83
GC-MS-based urine metabolic profiling of autism spectrum disorders. Anal Bioanal Chem (2013) 0.82
FG syndrome: linkage analysis in two families supporting a new gene localization at Xp22.3 [FGS3]. Am J Med Genet (2002) 0.82
TM4SF2 gene involvement reconsidered in an XLMR family after neuropsychological assessment. Am J Med Genet (2002) 0.82
Haploinsufficiency of the GPD2 gene in a patient with nonsyndromic mental retardation. Hum Genet (2008) 0.82
Effect of the oligodendrocyte myelin glycoprotein (OMgp) on the expansion and neuronal differentiation of rat neural stem cells. Brain Res (2009) 0.82
Protein SUMOylation, an emerging pathway in amyotrophic lateral sclerosis. Int J Neurosci (2013) 0.81
X-linked mental retardation: a comprehensive molecular screen of 47 candidate genes from a 7.4 Mb interval in Xp11. Eur J Hum Genet (2006) 0.81
MECP2 gene mutations in non-syndromic X-linked mental retardation: phenotype-genotype correlation. Am J Med Genet A (2003) 0.80
Skewed X chromosome inactivation in carriers is not a constant finding in FG syndrome. Eur J Hum Genet (2003) 0.80
A rare motor neuron deleterious missense mutation in the DPYSL3 (CRMP4) gene is associated with ALS. Hum Mutat (2013) 0.80
Untargeted 1H-NMR metabolomics in CSF: toward a diagnostic biomarker for motor neuron disease. Neurology (2014) 0.79
The BDNF Val(66)Met polymorphism is associated with escitalopram response in depressed patients. Psychopharmacology (Berl) (2014) 0.79
Is NMR metabolic profiling of spent embryo culture media useful to assist in vitro human embryo selection? MAGMA (2012) 0.79
Transplantation of multipotent cells extracted from adult skeletal muscles into the subventricular zone of adult rats. J Comp Neurol (2005) 0.79
Idiopathic Parkinson's disease phenotype related to C9ORF72 repeat expansions: contribution of the neuropsychological assessment. BMC Res Notes (2013) 0.78
mRNA-selective translation induced by FSH in primary Sertoli cells. Mol Endocrinol (2012) 0.78
Urinary elimination of coproporphyrins is dependent on ABCC2 polymorphisms and represents a potential biomarker of MRP2 activity in humans. J Biomed Biotechnol (2011) 0.78
Combined 1H-NMR and 1H-13C HSQC-NMR to improve urinary screening in autism spectrum disorders. Analyst (2014) 0.78
A functional tetranucleotide (AAAT) polymorphism in an Alu element in the NF1 gene is associated with mental retardation. Neurosci Lett (2011) 0.78
Transmission disequilibrium study of an oligodendrocyte and myelin glycoprotein gene allele in 431 families with an autistic proband. Neurosci Res (2007) 0.77
Recurrent deletion of ZNF630 at Xp11.23 is not associated with mental retardation. Am J Med Genet A (2010) 0.77